Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Change in Account Payables: 2019-2025

Historic Change in Account Payables for Beam Therapeutics (BEAM) over the last 7 years, with Sep 2025 value amounting to -$1.6 million.

  • Beam Therapeutics' Change in Account Payables fell 127.00% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year increase of 629.37%. This contributed to the annual value of $1.8 million for FY2024, which is 123.85% up from last year.
  • According to the latest figures from Q3 2025, Beam Therapeutics' Change in Account Payables is -$1.6 million, which was down 160.14% from $2.6 million recorded in Q2 2025.
  • In the past 5 years, Beam Therapeutics' Change in Account Payables registered a high of $3.8 million during Q1 2025, and its lowest value of -$3.0 million during Q3 2023.
  • For the 3-year period, Beam Therapeutics' Change in Account Payables averaged around -$84,091, with its median value being -$550,000 (2024).
  • As far as peak fluctuations go, Beam Therapeutics' Change in Account Payables skyrocketed by 1,012.89% in 2021, and later crashed by 2,584.31% in 2023.
  • Quarterly analysis of 5 years shows Beam Therapeutics' Change in Account Payables stood at $2.2 million in 2021, then skyrocketed by 34.32% to $2.9 million in 2022, then plummeted by 160.97% to -$1.8 million in 2023, then spiked by 68.89% to -$550,000 in 2024, then plummeted by 127.00% to -$1.6 million in 2025.
  • Its last three reported values are -$1.6 million in Q3 2025, $2.6 million for Q2 2025, and $3.8 million during Q1 2025.